Form 8-K EXACT SCIENCES CORP For: May 02
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Börse:
-100,00%
Echtzeit-Aktienkurs Exact Sciences Corp
Bid:
Ask:
Nachrichten zur Exact Sciences Corp Aktie
Exact Sciences to participate in May investor conference
MADISON, Wis., May 2, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced…
Updated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score[®] Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients
· Oncotype DX[®] receives highest rating of all multigene tests in the guidelines for quality of evidence and strength of…
Global Liquid Biopsy Markets Report 2022-2027 Featuring Thermo Fisher Scientific, Guardant Health, EXACT Sciences Corp, Illumina, Bio - Rad Laboratories, Biocept, NeoGenomics, & Qiagen NV
DUBLIN, April 29, 2022 /PRNewswire/ -- The "Global Liquid Biopsy Market, Size, Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of…
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up
Robust performances by the Screening and Precision Oncology segments drove Exact Sciences (EXAS) first-quarter top line....…
How Exact Sciences Aims to Keep Its Lead in Cancer Tests
Exact Sciences raised its sales guidance for 2022 and said its Cologuard colon cancer test will prove more accurate than…
Exact Sciences (EXAS) Q1 2022 Earnings Call Transcript
EXAS earnings call for the period ending March 31, 2022....…
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
Exact Sciences (EXAS) delivered earnings and revenue surprises of 7.14% and 5.35%, respectively, for the quarter ended March 2022. Do…
Exact Sciences raises guidance after better-than-expected 1Q revenue
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K EXACT SCIENCES CORP For: Apr 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exact Sciences Announces First Quarter 2022 Results
Total first quarter revenue of $487M, including Screening revenue of $307M, Precision Oncology revenue of $153M, and COVID-19 testing revenue…
Exact Sciences (EXAS) Stock Moves -0.49%: What You Should Know
Exact Sciences (EXAS) closed at $60.68 in the latest trading session, marking a -0.49% move from the prior day....…
Exact Sciences schedules first quarter 2022 earnings call
MADISON, Wis., April 8, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced…
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Exact Sciences (EXAS) closed at $71.32, marking a -0.78% move from the previous day....…
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Exact Sciences (EXAS) closed at $57.56, marking a -1.96% move from the previous day....…
Exact Sciences (EXAS) Cologuard Sales Up but Costs Rise
Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer....…
Exact Sciences (EXAS) Gains But Lags Market: What You Should Know
Exact Sciences (EXAS) closed at $72.26 in the latest trading session, marking a +0.81% move from the prior day....…
Insiderhandel: President and CEO verkauft Aktien von Exact Sciences im Wert von 1.096.590$
Conroy, Kevin T. - Vorstand - Tag der Transaktion: 2022-03-01...…
Insiderhandel: Chief Financial Officer verkauft Aktien von Exact Sciences im Wert von 310.595$
Elliott, Jeffrey Thomas - Vorstand - Tag der Transaktion: 2022-03-01...…
Insiderhandel: Chief Legal Officer verkauft Aktien von Exact Sciences im Wert von 300.011$
Coward, D Scott - Vorstand - Tag der Transaktion: 2022-03-01...…
Insiderhandel: SVP, Human Resources verkauft Aktien von Exact Sciences im Wert von 330.662$
Condella, Sarah - Vorstand - Tag der Transaktion: 2022-02-24...…
Insiderhandel: General Manager, New Ventures verkauft Aktien von Exact Sciences im Wert von 77.681$
Orville, Jacob A. - Vorstand - Tag der Transaktion: 2022-02-23...…
Insiderhandel: Chief Financial Officer verkauft Aktien von Exact Sciences im Wert von 107.511$
Elliott, Jeffrey Thomas - Vorstand - Tag der Transaktion: 2022-02-23...…
Insiderhandel: SVP, Human Resources verkauft Aktien von Exact Sciences im Wert von 77.612$
Condella, Sarah - Vorstand - Tag der Transaktion: 2022-02-23...…
Insiderhandel: President and CEO verkauft Aktien von Exact Sciences im Wert von 358.231$
Conroy, Kevin T. - Vorstand - Tag der Transaktion: 2022-02-23...…
Where Exact Sciences Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically…
Exact Sciences Clocks 16% Jump In Q4 Non-COVID-19 Revenues
Exact Sciences Corps (NASDAQ: EXAS) Q4 revenues increas
read more...…
Cancer-Test Maker Exact Sciences Saw Strong Revenue Growth
Exact Sciences, known for its Cologuard cancer test, reported good revenue growth in its December quarter. The follow-up conference call…
Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down
Exact Sciences (EXAS) legacy Screening business saw strong momentum on solid Cologuard volume growth during the fourth quarter....…
Exact Sciences (EXAS) Q4 2021 Earnings Call Transcript
EXAS earnings call for the period ending December 31, 2021....…
Exact Sciences Corporation (EXAS) CEO Kevin Conroy on Q4 2021 Results - Earnings Call Transcript
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Exact Sciences (EXAS) delivered earnings and revenue surprises of -40.66% and 0.15%, respectively, for the quarter ended December 2021. Do…
Exact Sciences cuts quarterly loss 47%, but still misses on bottom line consensus
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 10-K EXACT SCIENCES CORP For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exact Sciences Announces Fourth Quarter 2021 Results
MADISON, Wis., Feb. 22, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced…
Form 8-K EXACT SCIENCES CORP For: Feb 22
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Exact Sciences (EXAS) closed at $74.13 in the latest trading session, marking a -0.86% move from the prior day....…
Insiderhandel: Chief Administrative Officer verkauft Aktien von Exact Sciences im Wert von 144.224$
Coward, D Scott - Vorstand - Tag der Transaktion: 2022-02-15...…
Insiderhandel: General Manager, New Ventures verkauft Aktien von Exact Sciences im Wert von 74.777$
Orville, Jacob A. - Vorstand - Tag der Transaktion: 2022-02-15...…
Insiderhandel: President and CEO verkauft Aktien von Exact Sciences im Wert von 1.146.236$
Conroy, Kevin T. - Vorstand - Tag der Transaktion: 2022-02-15...…
Insiderhandel: SVP, Human Resources verkauft Aktien von Exact Sciences im Wert von 74.618$
Condella, Sarah - Vorstand - Tag der Transaktion: 2022-02-15...…
Insiderhandel: Chief Financial Officer verkauft Aktien von Exact Sciences im Wert von 146.292$
Elliott, Jeffrey Thomas - Vorstand - Tag der Transaktion: 2022-02-15...…
A First Take On Exact Sciences
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
Exact Sciences (EXAS) closed at $78.75 in the latest trading session, marking a +0.85% move from the prior day....…
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
Exact Sciences (EXAS) closed the most recent trading day at $77.40, moving +1.36% from the previous trading session....…
Exact Sciences to participate in February investor conferences
MADISON, Wis., Feb. 1, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in…
Form 8-K EXACT SCIENCES CORP For: Jan 25
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Exact Sciences (EXAS) closed the most recent trading day at $68.89, moving -0.42% from the previous trading session....…
Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients
MADISON, Wis., Jan. 18, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced performance data for a second-generation Cologuard…
Exact Sciences announces improved accuracy of second-generation Cologuard test
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…